Is BIIB up or down today?
BIIB is up 0.80% today, last at 217.15. This stock moved +0.80% versus the prior close.
BIIB · Biogen
BIIB (Biogen) is trading at 217.15, up 0.80% on the session. BIIB sits at the 90% mark of its 52-week range, carries a 14-day RSI of 53, and trades above its 50-day average. Over the past month it is up 3.96%.
Leading the coverage: “(BIIB) Movement as an Input in Quant Signal Sets - Stock Traders Daily” (Google News, 3d ago). BIIB is -1.67% since story.
BIIB trades on a trailing P/E of 38.3 and is running 5.02% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
BIIB is up 0.80% today, last at 217.15. This stock moved +0.80% versus the prior close.
Leading the coverage: “(BIIB) Movement as an Input in Quant Signal Sets - Stock Traders Daily” (Google News, 3d ago). BIIB is -1.67% since story. Dominant story: Biogen (BIIB) Sees Canada Back LEQEMBI As Fair Value Stays In Focus - simplywall.st (1 source, neutral) RSI is 53 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (126 days) · Drag or scroll left for earlier dates
Biogen (BIIB) Sees Canada Back LEQEMBI As Fair Value Stays In Focus - simplywall.st
BIIB Maintained by HSBC -- Price Target Raised to $175 - GuruFocus
Biogen Inc. stock gains on fresh analyst upgrades and strong Q2 figures - ad-hoc-news.de
Stifel reiterates Biogen stock rating on immunology pipeline - Investing.com
HSBC Maintains Reduce on Biogen, Raises Price Target to $175